A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection
Abstract
Viral myocarditis is a leading cause of death in the United States, contributing to numerous unexplained deaths in people ≤35 years old. Enteroviruses contribute to many cases of human myocarditis. Encephalomyocarditis virus (EMCV) infection causes viral myocarditis in rodent models, but its receptor requirements have not been fully identified. CRISPR-Cas9 screens can identify host dependency factors essential for EMCV infection and enhance our understanding of key events that follow viral infection, potentially leading to new strategies for preventing viral myocarditis. Using a CRISPR-Cas9 screen, we identified a d isintegrin a nd m etalloproteinase 9 domain (ADAM9) as a major factor required for the early stages of EMCV infection in both human and murine infection.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 26, 2019
- Source ID
- 10.1128/mbio.02734-18
Entities
People
- Abraham L. Brass
- Caroline A Owen
- Christopher R. Mackay
- Daniel Lindstrom
- Evelyn A. Kurt-jones
- Jennifer P Wang
- Joselyn Rojas-quintero
- Lindsey E. Bazzone
- Michael King
- Paul Meraner
- Pyae P. Kyawe
- Robert W. Finberg
Organizations
- American Heart Association
- Burroughs Wellcome Fund
- Congressionally Directed Medical Research Programs
- Gates Foundation
- Gilead Sciences
- Harvard Medical School
- National Institute of Allergy and Infectious Diseases
- University of Massachusetts Medical School